Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02432092 · ClinicalTrials.gov registry record

Pediatric Cardiomyopathy Mutation Analysis

A clinical trial of Cardiomyopathies and Hypertrophic Cardiomyopathy, sponsored by Indiana University.

Recruiting
Registry status
300
Enrollment target
1
Study location

NCT02432092 is a study of Cardiomyopathies and Hypertrophic Cardiomyopathy that is actively recruiting participants, run by Indiana University. The registered enrollment target is 300 participants, below the 618-participant average among 17 other Cardiomyopathies trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02432092, a study of Cardiomyopathies and Hypertrophic Cardiomyopathy, is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
300 participants
Enrollment target
1
Study location

Study Summary

The goal of this protocol is to obtain information from individuals with cardiomyopathy and from their families in order to elucidate the molecular genetics of this disorder. This will provide the basis for future genetic counseling as well as contribute to elucidating the biology of normal and abnormal cardiac function.

Study Locations (1)

Indiana

  • IU School of Medicine - Indianapolis

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2014-04
Est. Completion 2030-12-31

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT02432092

The ClinicalTrials.gov registry entry for NCT02432092 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 618-participant average among 17 other Cardiomyopathies trials with a reported enrollment target (51% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Cardiomyopathies appearing as the primary indexed condition, and to 0 interventions.

NCT02432092 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT02432092 about?

NCT02432092 is a clinical study titled "Pediatric Cardiomyopathy Mutation Analysis". The goal of this protocol is to obtain information from individuals with cardiomyopathy and from their families in order to elucidate the molecular genetics of this disorder. This will provide the basis for future genetic counseling as well as contribute to elucidating the biology of normal and abno...

What is the current status of trial NCT02432092?

This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2014-04. Estimated completion is 2030-12-31.

What conditions does trial NCT02432092 study?

This clinical trial studies the following conditions: Cardiomyopathies, Hypertrophic Cardiomyopathy, Dilated Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy, Restrictive Cardiomyopathy.

Who is sponsoring clinical trial NCT02432092?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02432092 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiomyopathies

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.